NIH-funded research R01 grant

Understanding how immune system issues affect wound healing in a rare childhood disease.

Official title: Crosstalk of Immune Dysregulation and Impaired Wound Healing in inherited STAT4-mediated Autoinflammatory Disease

Funded at University of California, San Diego · NIH-11105513 · Data updated 2026-11-12

This study is looking at how a specific change in a gene might be causing ongoing inflammation and slow healing in people with a condition called disabling pansclerotic morphea, with the goal of finding new ways to help improve healing and overall health for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startFebruary 1, 2025
Project endJanuary 31, 2030
Funding year2025
Award (this year)$385,575
NIH project number1R01AI189984-01
Project IDNIH-11105513 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children diagnosed with disabling pansclerotic morphea who exhibit symptoms of immune dysregulation.

Less likely to help

Patients with other forms of skin disorders or those without the specific STAT4 mutation may not benefit from this research.

What this research studies

This research investigates the role of a specific genetic mutation in the STAT4 gene that causes immune dysregulation and impaired wound healing in patients with disabling pansclerotic morphea (DPM). The study aims to understand how this mutation leads to persistent inflammation and affects the development and activation of immune cells. By exploring the mechanisms involved, the researchers hope to identify potential therapeutic targets that could improve wound healing and overall patient outcomes. The approach includes both laboratory experiments and clinical observations to validate findings.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve wound healing and quality of life for patients with DPM.

How similar studies have gone: Previous research has shown promising results in targeting immune dysregulation in similar autoinflammatory diseases, suggesting potential for success in this approach.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Broderick, Lori — University of California, San Diego
  • Study coordinator: Broderick, Lori

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.